Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.

Source: [NBC News](https://www.nbcnews.com/health/cancer/personalized-mrna-vaccine-melanoma-cut-risk-cancers-return-late-stage-rcna605208)

Sponsored